Chromoendoscopy with hematoxylin in the classificaton of gastric lesions

Gastric Cancer

Volumn 11, Issue 1, 2008, Pages 15-21

  Mouzyka, Serguei ^a   Fedoseeva, Alexandra ^a  

^a Hospital LISSOD   (Ukraine)

Author keywords

Chromoendoscopy; Endoscopy; Hematoxylin

Indexed keywords

CYCLINE; HEMATOXYLIN; MONOCLONAL ANTIBODY; COLORING AGENT; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ACCURACY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CELL PROLIFERATION; CHROMOENDOSCOPY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STAINING; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CANCER; EPITHELIUM; GASTROSCOPY; IMAGE ENHANCEMENT; METHODOLOGY; MIDDLE AGED; PATHOLOGY; STOMACH MUCOSA;

ADULT; AGED; AGED, 80 AND OVER; COLORING AGENTS; CONTRAST MEDIA; EPITHELIUM; FEMALE; GASTRIC MUCOSA; GASTROSCOPY; HEMATOXYLIN; HUMANS; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYLORIC ANTRUM;

EID: 41549151681     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-007-0445-4     Document Type: Article

References (31)

1. Lambert R. What is the role of individual screening in the prevention of digestive cancer? Gastrointest Endosc 2003;53:401-3.
2. Fennerty MB. Tissue staining. Gastrointest Endosc Clin N Am 1994;4:297-311.
3. Shim CS. Staining in gastrointestinal endoscopy: clinical application and limitations. Endoscopy 1999;31:487-96.
4. Walter JB, Talbot IC. General pathology. New York: Churchill Livingstone; 1996.
5. Lillie RD. Histopathologic technique and practical histochemistry. New York: McGraw-Hill; 1965.
6. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, et al. The Vienna classifi cation of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
7. Trosko JE. Role of low-level ionizing radiation in multi-step carcinogenic process. Health Phys 1996;70:812-22.
8. Canto MI. Staining in gastrointestinal endoscopy: the basics. Endoscopy 1999;31:479-86.
9. Endoscopic Classifi cation Review Group. Update on the Paris classifi cation of superfi cial neoplastic lesions in the digestive tract. Endoscopy 2005;37:570-8.
10. Hosokawa O, Tsuda S, Kidani E, Watanabe K, Tanigawa Y, Shirasaki S, et al. Diagnosis of gastric cancer up to 3 years after negative upper gastrointestinal endoscopy. Endoscopy 1998;30: 669-74.
11. Suzuka I, Daidoji H, Matsuoka M, Kadowaki K, Takasaki Y, Nakane PK, et al. Gene for proliferating-cell nuclear antigen (DNA polymerase delta auxiliary protein) is present in both mammalian and higher plant genomes. Proc Natl Acad Sci USA 1989;86:3189-93.
12. Travali S, Ku D-H, Rizzo MG, Ottavio L, Baserga R, Calabretta B. Structure of the human gene for the proliferating cell nuclear antigen. J Biol Chem 1989;264:7466-72.
13. Yamamoto T, Mori Y, Ishibashi T, Uchiyama Y, Ueda T, Ando T, et al. Interaction between proliferating cell nuclear antigen (PCNA) and a DnaJ induced by DNA damage. J Plant Res 2005; 118:91-7.
14. Goldsby RE, Hays LE, Chen X, Olmsted EA, Slayton WB, Spangrude GJ, et al. High incidence of epithelial cancers in mice defi cient for DNA polymerase delta proofreading. Proc Natl Acad Sci USA 2002;99:15560-5.
15. Wolf HK, Michalopoulos GK. Hepatocyte regeneration in acute fulminant and non-fulminant hepatitis: a study of proliferating cell nuclear antigen expression. Hepatology 1992;49:707-13.
16. Kawakita N, Seki S, Sakaguchi H, Yanai A, Kuroki T, Mizoguchi Y, et al. Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fi xed in formaldehyde. Am J Pathol 1992;140:513-20.
17. Kullmann F, Fadaie M, Gross V, Knuchel R, Bocker T, Steinbach P, et al. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996;8:371-9.
18. Can B, Sökmensüer C. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors. Hepatogastroenterology 2003;50(Suppl 2):ccxliii-viii.
19. Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, et al. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. J Surg Oncol 2003;82:247-55.
20. Ozercan IH, Bahcecioglu IH, Ozercan MR, Bozlak N, Dogan C, Yekeler H. Proliferating cell nuclear antigen and nucleolar organizer region for differential diagnosis of dysplasia and adenocarcinoma in gastric biopsies. Indian J Gastroenterol 2000;19:57-60.
21. Tseng HH, Hsu PI, Chen HC, Lai KH, Lo GH, Lo CC, et al. Compartment theory in Helicobacter pylori-associated gastric carcinogenesis. Anticancer Res 2003;23:3223-9.
22. Lee KE, Lee HJ, Kim YH, Yu HJ, Yang HK, Kim WH, et al. Prognostic signifi cance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol 2003;33:173-9.
23. Hirose K, Iida A, Yamaguchi A, Onchi H, Awata H, Katayama K, et al. Prognostic value of DNA ploidy and proli ferating cell nuclear antigen in gastric cancer. Oncology 1998;55: 300-6.
24. Terada R, Yasutake T, Nakamura S, Hisamatsu T, Nakagoe T, Ayabe H, et al. Evaluation of metastatic potential of gastric tumors by staining for proliferating cell nuclear antigen and chromosome 17 numerical aberrations. Ann Surg Oncol 2001;8: 525-32.
25. Matturri L, Biondo B, Cazzullo A, Colombo B, Giordano F, Guarino M, et al. Prognostic signifi cance of different biological markers (DNA index, PCNA index, apoptosis, p53, karyotype) in 126 adenocarcinoma gastric biopsies. Anticancer Res 1998;18: 2819-25.
26. Czyzewska J, Guzinska-Ustymowicz K, Lebelt A, Zalewski B, Kemona A. Evaluation of proliferating markers Ki-67, PCNA in gastric cancers. Rocz Akad Med Bialymst 2004;49(Suppl 1): 64-6.
27. Wu K, Zhao L, Li Y, Shan YJ, Wu LJ. Effects of vitamin E succinate on the expression of Fas and PCNA proteins in human gastric carcinoma cells and its clinical signifi cance. World J Gastroenterol 2004;10:945-9.
28. Ji SQ, Hua YW, Zhuang J, Gao Y, Kong Y, Han SL, et al. Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior (in Chinese). Ai Zheng 2002;21:619-24.
29. Rokkas T, Liatsos C, Karameris A, Petridou E, Lazaris A, Antoniades D, et al. Proliferating cell nuclear antigen (PCNA) immunostaining in Helicobacter pylori infection: impact of eradication. Pathol Oncol Res 1999;5:304-8.
30. Nagata J, Kijima H, Takagi A, Ito M, Goto K, Yamazaki H, et al. Helicobacter pylori induces chronic active gastritis in p53-knockout mice. Int J Mol Med 2004;13:773-7.
31. Unger Z, Molnar B, Szaleczky E, Torgyekes E, Muller F, Zagoni T, et al. Effect of Helicobacter pylori infection and eradication on gastric epithelial cell proliferation and apoptosis. J Physiol Paris 2001;95:355-60.